Pharmaceutical As advocates for a World Health Organization proposal to temporarily waive intellectual property protections for COVID-19 vaccines try to win more support from developed countries, one obstacle to reaching consensus is whether compulsory licenses will require pharmaceutical companies to divulge trade secrets, say experts reported by Law360, a LexisNexis which is providing free access to its coronavirus coverage in an effort to ensure the legal community has accurate information. 26 May 2021